Measuring Transplant Center Performance: the Goals Are Not Controversial but the Methods and Consequences Can Be

被引：39

作者：

Jay C. ^{[1
]}

Schold J.D. ^{[2
,3
]}

机构：

[1] University Transplant Center, University of Texas Health, San Antonio, 78229, TX

[2] Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

[3] Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH

来源：

Current Transplantation Reports | 2017年 / 4卷 / 1期

基金：

美国国家卫生研究院;

关键词：

Centers for Medicare and Medicaid Services; Membership and Professional Standards Committee; Organ Procurement and Transplant Network; Organ transplantation; Performance metrics; Quality; Regulatory oversight;

D O I：

10.1007/s40472-017-0138-9

中图分类号：

学科分类号：

摘要：

Purpose of Review: Risks of regulatory scrutiny has generated widespread concern about increasingly risk averse transplant center behaviors regarding both donor and candidate acceptance patterns. To address potential unintended consequences threatening access to care, we discuss recent changes in regulatory metrics and potential improvements in quality oversight of transplant centers. Recent Findings: Despite many recent changes to 1-year patient and graft survival regulatory criteria, the capacity to accurately identify true underperforming centers and avoiding false positive flagging remains an area of great concern. Numerous studies have demonstrated restrictions in transplant volume and access following transplant center flagging. Summary: Current regulatory criteria are limited in their capacity to accurately identify poorly performing centers and potentially encourage risk averse behavior by transplant centers. Efforts to address these concerns should focus on (1) improving risk adjustment models with better data which captures the acuity of candidate and donor risk, (2) reconsidering primary outcomes measured to assess comprehensive transplant center performance, (3) improving education to address rational or perceived disincentives, and (4) using data more effectively to share best practices. © 2017, Springer International Publishing AG.

引用

页码：52 / 58

页数：6

共 32 条

[11]

Massie A.B., Segev D.L., Rates of false flagging due to statistical artifact in CMS evaluations of transplant programs: results of a stochastic simulation, Am J Transplant, 13, pp. 2044-2051, (2013)

[12]

Schold J.D., Miller C.M., Henry M.L., Et al., Evaluation of flagging criteria of United States kidney transplant center performance: how to best define outliers?, Transplantation, 2016

[13]

Schold J.D., Howard R.J., Prediction models assessing transplant center performance: can a little knowledge be a dangerous thing?, Am J Transplant, 6, pp. 245-246, (2006)

[14]

White S.L., Zinsser D.M., Paul M., Et al., Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs, Health Serv Res, 50, pp. 330-350, (2015)

[15]

Schold J.D., Buccini L.D., Srinivas T.R., Et al., The association of center performance evaluations and kidney transplant volume in the United States, Am J Transplant, 13, pp. 67-75, (2013)

[16]

Schold J.D., Arrington C.J., Levine G., Significant alterations in reported clinical practice associated with increased oversight of organ transplant center performance, Prog Transplant, 20, pp. 279-287, (2010)

[17]

Schold J.D., Buccini L.D., Goldfarb D.A., Et al., Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis, Clin J Am Soc Nephrol, 9, pp. 1773-1780, (2014)

[18]

Buccini L.D., Segev D.L., Fung J., Et al., Association between liver transplant center performance evaluations and transplant volume, Am J Transplant, 14, pp. 2097-2105, (2014)

[19]

Rao P.S., Merion R.M., Ashby V.B., Et al., Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients, Transplantation, 83, pp. 1069-1074, (2007)

[20]

Wolfe R.A., Ashby V.B., Milford E.L., Et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, 341, pp. 1725-1730, (1999)

← 1 2 3 4 →